A hemolysis index is a number that tells a laboratory how much a blood sample has been damaged by the rupture of red blood cells before or during analysis. Modern clinical analyzers measure it automatically because when red blood cells break open, their contents spill into the surrounding serum or plasma and can throw off the results of dozens of common tests.1The Journal of Applied Laboratory Medicine. The Impact of Hemolysis-Index Thresholds on Plasma and Serum Potassium Measurements The index matters because it is effectively a quality-control gate: it flags which results you can trust and which you should throw out and redraw.
How a Hemolysis Index Is Measured
When red blood cells burst, they release hemoglobin into the liquid portion of the blood sample. Hemoglobin has a distinctive color, and like any colored substance, it absorbs light at predictable wavelengths. Lab analyzers exploit this by shining light through the sample and measuring how much gets absorbed in the hemoglobin-sensitive range, typically around 570 to 600 nanometers.2Academic Pathology. Educational Case: Hemolysis and Lipemia Interference With Laboratory Testing One widely used platform, for example, takes a tiny aliquot of the patient’s specimen, dilutes it in saline, and reads absorbance at 570 nm as the primary wavelength and 600 nm as the secondary, with additional wavelengths checked for lipemia and jaundice.3The Journal of Applied Laboratory Medicine. Automated Measurement of Plasma Cell-Free Hemoglobin Using the Hemolysis Index Check Function Other analyzers use slightly different wavelength pairs, with one study evaluating four combinations spanning roughly 410 to 596 nm to find which correlated best with actual hemoglobin concentration.4PubMed Central. Determination of the Optimal Wavelength of the Hemolysis Index Measurement
The analyzer converts the absorbance reading into a semiquantitative score, often expressed as an index value or as an estimated concentration of free hemoglobin in grams per liter. That score is then compared against thresholds the lab has set for each test. If the hemolysis index is below the threshold for a particular assay, the result is reported normally. If it exceeds the threshold, the lab either flags the result with a warning or rejects it outright and asks for a new sample.
Why the Old Method Fell Short
Before automated hemolysis indices became standard, lab staff judged hemolysis by eye. A trained technician would look at the separated serum or plasma and estimate the degree of redness on a rough scale. The problem is that human eyes are surprisingly unreliable for this task. In a study of over 1,500 samples, the agreement between automated detection and visual inspection for hemolysis was poor, and agreement among different observers was only moderate at best.5PubMed Central. Evaluation of Visual Serum Indices Measurements and Potential False Result Risks in Routine Clinical Chemistry Tests in Addis Ababa, Ethiopia The same study found that visual inspection led observers to falsely accept results for tests like CK-MB and LDH that should have been flagged, while simultaneously rejecting chloride and sodium results that were fine. Subtle color differences in specimens are hard to distinguish, and the job gets even harder when the sample is also yellowish from bilirubin or cloudy from lipids.2Academic Pathology. Educational Case: Hemolysis and Lipemia Interference With Laboratory Testing
The shift to automated detection improved both reproducibility and the ability to catch mildly hemolyzed specimens, particularly those with free hemoglobin below about 0.6 grams per liter, which are nearly impossible to see with the naked eye.6Biochemia Medica. Hemolysis detection and management of hemolyzed specimens Some smaller labs still rely on visual grading, but the clear trend in the field is toward automated indices, and professional groups have called for standardized reporting of these measurements across all sample types.7The Journal of Applied Laboratory Medicine. Handling Hemolytic Blood Samples from High-Risk Clinical Areas: A Call to Action
How Hemolysis Wrecks Lab Results
Hemolysis does not wreck results in just one way. It interferes through at least four distinct mechanisms: it adds color that confuses the instrument’s optics, it dumps intracellular molecules into the sample, it dilutes the serum slightly with the fluid released from burst cells, and the released substances can chemically react with assay components.8PubMed. Managing hemolyzed samples in clinical laboratories
The optical interference is straightforward: free hemoglobin absorbs light at many of the same wavelengths that analyzers use to measure other substances, so the machine reads hemoglobin’s color as though it were the thing being tested. In coagulation testing, for example, optical instruments can misread clotting endpoints when free hemoglobin is absorbing light in the working range. But the biological interference from released cellular contents is often worse. Ruptured red blood cells release tissue factor, proteases, phospholipids, and ADP, all of which can activate clotting pathways and platelets, creating spurious results in hemostasis assays that have nothing to do with the patient’s actual clotting ability.9PubMed. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia
The Potassium Problem
Potassium is the most commonly discussed casualty of hemolysis, and for good reason. Red blood cells contain far more potassium inside them than exists in the surrounding plasma. When those cells break open, even modest hemolysis floods the sample with potassium and can push a normal reading into the range that looks like hyperkalemia, a potentially dangerous elevation that might trigger urgent treatment.10PubMed. Accurate correction model of blood potassium concentration in hemolytic specimens
An emergency department study examined cases where hemolyzed samples showed elevated potassium levels. The median hemolyzed potassium was 5.8 millimoles per liter, well into the abnormal range. But when those same patients had blood redrawn and the new sample was not hemolyzed, the median potassium dropped to 3.9 millimoles per liter, which is perfectly normal. Not a single patient in the study had true hyperkalemia on the repeat draw.11PubMed Central. Accuracy of Hemolyzed Potassium Levels in the Emergency Department The gap between the hemolyzed and non-hemolyzed values was enormous, and there was essentially no correlation between how high the hemolyzed sample read and what the patient’s actual potassium level was. This makes the hemolysis index critical: without it, a clinician might treat a patient for a dangerous electrolyte imbalance that does not actually exist.
Beyond Potassium
Potassium gets the headlines, but hemolysis distorts other tests too. Lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) are both enzymes found in high concentrations inside red blood cells, so hemolyzed samples tend to show artificially elevated levels of both. Cardiac troponin T, a critical marker for diagnosing heart attacks, is affected in a different and more insidious way. Research has shown that hemolysis causes troponin T levels to decrease in the sample, because proteases released from ruptured cells degrade the troponin protein. At a hemoglobin level of about 0.75 grams per liter, troponin T dropped by more than ten percent, enough to potentially mask a heart attack that was actually happening.12PubMed. Mechanism of interference by haemolysis in the cardiac troponin T immunoassay So hemolysis does not always push numbers up. Depending on the test, it can push them down, which is arguably more dangerous because the falsely low result can provide false reassurance.
What Causes Samples to Hemolyze
The overwhelming majority of hemolyzed samples arrive that way because of something that went wrong during collection or transport, not because of a disease process in the patient. This is called in vitro hemolysis, and it dwarfs in vivo hemolysis in frequency. Common culprits include difficult draws where the needle is too small or the vacuum too strong, drawing blood through an IV catheter instead of a clean venipuncture, excessive shaking or rough handling of tubes, and delays in processing.
Drawing blood through an IV catheter is one of the most reliable ways to damage red blood cells. In one study, blood drawn through IV catheters hemolyzed at a rate of about 14%, compared with roughly 4% for samples collected by standard venipuncture.13PubMed. A comparison of hemolysis rates using intravenous catheters versus venipuncture tubes for obtaining blood samples Emergency departments are especially prone to this because patients frequently already have an IV in place, and it feels faster to draw from an existing line than to perform a separate puncture. When one ED switched to a dedicated blood-collection method designed to reduce shear forces during the draw, their hemolysis rate dropped from about 7% to under 2%.14PubMed Central. Hemolysis Control in the Emergency Department by Interventional Blood Sampling
Pneumatic tube systems, the pressurized capsule networks that whoosh samples from the ER to the lab, have been investigated extensively. One early study found a dramatically higher hemolysis rate in tube-transported samples compared to hand-carried ones.15PubMed Central. Hemolysis associated with pneumatic tube system transport for blood samples But a later meta-analysis pooling many studies together found no significant overall difference in hemolysis rates between pneumatic tubes and manual transport, with one exception: LDH levels were higher in pneumatic-tube samples, but only when the system speed exceeded about 6 meters per second or the travel distance was over 250 meters.16PubMed. Effects of a pneumatic tube system on the hemolysis of blood samples: a PRISMA-compliant meta-analysis Researchers have used data loggers to track what happens inside the capsules, and the degree of hemolysis correlates with the g-forces the sample experiences, which in turn depend on speed and how many sharp turns the tube takes.17Clinical Chemistry. Determination of Hemolysis Thresholds by the Use of Data Loggers in Pneumatic Tube Systems The takeaway is that pneumatic tubes are fine in most hospitals, but each system needs to be validated locally, because a slow, short route is a very different thing from a fast, winding one.
In Vivo Versus In Vitro Hemolysis
When a sample comes back hemolyzed, the lab’s first instinct is to blame the collection process. That instinct is usually correct, but not always. Some patients genuinely have hemolysis happening inside their bodies. Conditions like autoimmune hemolytic anemia, sickle cell crises, transfusion reactions, malaria, and mechanical heart valves can all shatter red blood cells in the circulation. Distinguishing between in vivo and in vitro hemolysis matters because the two require very different responses. If the problem is a bad draw, you just need a new sample. If the problem is a disease breaking down the patient’s red cells, the hemolyzed result is real clinical information, not an artifact to discard.
Labs rely on clinicians to supply the clinical context needed to make this distinction.18PubMed Central. Hemolyzed Specimens: Major Challenge for Identifying and Rejecting Specimens in Clinical Laboratories Some clues help: if the hemolysis index is elevated but the patient has no known hemolytic condition, and if a fresh draw comes back clean, the first sample was almost certainly damaged in vitro. If both draws come back hemolyzed, or if the patient has a clinical picture consistent with hemolysis, the lab should not simply reject the sample. Effective processes for identifying unsuitable specimens, differentiating the two types, and troubleshooting causes are considered essential in modern laboratory practice.19PubMed. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories
The Cost of Hemolyzed Samples
Hemolysis is not just a lab headache. It has real consequences for patients and hospitals. When a sample is rejected for hemolysis, a phlebotomist has to go back to the patient, perform another blood draw, send the new sample to the lab, and wait for fresh results. All of that takes time. In one large study, patients whose samples were hemolyzed spent an average of about an hour longer in the emergency department than patients whose samples were clean.20PubMed. Seeing Red: Blood Sample Hemolysis Is Associated with Prolonged Emergency Department Throughput The delay was even larger for patients who were eventually discharged, averaging about 90 extra minutes compared to the non-hemolyzed group.
Financially, the impact adds up fast. One analysis estimated that for a busy emergency department seeing 100,000 patients a year, with a 40% rate of chemistry panels drawn and a 10% hemolysis incidence, the direct cost of hemolysis-related delays and redraws ran to roughly four million dollars annually.21Journal of Applied Laboratory Medicine. The Hidden Cost of Hemolyzed Blood Samples in the Emergency Department That figure accounts for the downstream effects of keeping patients in the ED longer: bed occupancy, staff time, supply consumption, and the opportunity cost of not being able to see other patients. It makes hemolysis one of the most expensive preanalytical errors in medicine.
Why Mathematical Corrections Do Not Work
An intuitive idea is to just correct for hemolysis mathematically. If you know how much hemoglobin leaked, why not calculate how much potassium or LDH came with it and subtract that from the result? Researchers have tried. The problem is that the leakage is not uniform. How much potassium spills out of a burst red blood cell depends on the individual patient’s cell composition, which varies from person to person and even from day to day. A study that tested corrective formulas on mechanically hemolyzed samples found that the error did not occur predictably enough across different subjects to make the adjustments reliable. The researchers concluded that releasing corrected results on hemolyzed specimens was not just unreliable but potentially misleading.22Biochemia Medica. Studies on in vitro hemolysis and utility of corrective formulas for reporting results on hemolyzed specimens This is why labs generally reject hemolyzed samples and request new ones, rather than trying to salvage the numbers.
The Standardization Gap
One persistent frustration in the field is that different analyzer platforms do not report hemolysis indices in the same way. Two machines measuring the same sample can return different index values because they use slightly different wavelengths, different calibration materials, and different scales. A hemolysis index of 50 on one platform is not the same thing as a hemolysis index of 50 on another. This means that a threshold set as acceptable on one system might not translate to the next, and labs that switch platforms or run multiple systems cannot simply carry over their old rules.23PubMed. Harmonization of automated hemolysis index assessment and use: Is it possible?
The lack of harmonization extends beyond the number itself. Different labs set different rejection thresholds for the same test, format their reports differently, and handle flagged results with different policies. There have been calls for professional organizations to develop standardized approaches to reporting hemolysis indices, including common thresholds, interpretation criteria, and report formats, but as of now, much of this remains locally determined.7The Journal of Applied Laboratory Medicine. Handling Hemolytic Blood Samples from High-Risk Clinical Areas: A Call to Action
Neonates and Other High-Risk Groups
Some patient populations are hemolysis magnets. Neonatal intensive care units are the worst offenders. Tiny veins, small blood volumes, and difficult collection techniques conspire to make hemolysis rates soar. Reports from some NICUs put the hemolysis rate as high as 70%, particularly in the most premature infants.7The Journal of Applied Laboratory Medicine. Handling Hemolytic Blood Samples from High-Risk Clinical Areas: A Call to Action Blood is often collected by heel stick, and the bleeding site is squeezed or “milked” to get enough volume, which physically destroys red blood cells and leaks intracellular potassium into the sample. Syringe draws, common in neonates, also subject blood to repeated shear forces that promote lysis.
The challenge in neonates is amplified by the fact that you cannot simply redraw the blood whenever you want. Every milliliter taken from a premature infant is a significant proportion of their total blood volume. Repeated draws can contribute to iatrogenic anemia. So labs and clinicians face a real dilemma: the sample is hemolyzed, but redrawing has its own risks. This is one area where emerging technology aimed at detecting hemolysis in smaller, whole-blood samples could make a meaningful clinical difference.
Detecting Hemolysis in Whole Blood
Conventional hemolysis-index measurement requires a centrifuged sample, because you need to separate the plasma or serum from the cells before you can look at the color of the liquid. That step takes time and is impractical for point-of-care testing, such as blood gas analyzers at the bedside. Newer devices are trying to close this gap.
One approach uses acoustofluidic technology. Acoustic energy creates a standing wave inside a tiny chamber, pushing red blood cells to one side so that a clear pocket of plasma can be measured optically, all without actually spinning the sample in a centrifuge. A new blood gas analyzer uses this principle on just two microliters of whole blood, separating plasma locally within the device and then reading hemoglobin absorbance at 570 nm and 610 nm.24Clinical Chemistry. Novel In-Line Hemolysis Detection on a Blood Gas Analyzer and Impact on Whole Blood Potassium Results 25PubMed Central. Improved potassium reliability in whole blood through hemolysis detection on the novel GEM Premier 7000 blood gas analyzer This allows the instrument to flag hemolysis and suppress unreliable potassium results before they ever reach the clinician, something that was previously impossible on a blood gas platform.
A separate research effort has developed an optofluidic sensor that uses nanofilters on an optical waveguide to measure hemoglobin in plasma directly from unseparated whole blood. The sensor works across a wide range of hematocrit levels and produces results in under 60 seconds, without any centrifugation or extra sample preparation.26ACS Sensors. Optofluidic Sensor for Inline Hemolysis Detection on Whole Blood Technologies like these point toward a future where hemolysis is caught at the point of care, before results are acted on, rather than discovered later in the central lab after clinical decisions may already have been made.